跳至主要内容
临床试验/NCT03540680
NCT03540680进行中(未招募)不适用

Case-control Study Evaluating the Impact of p16Ink4a in Bronchopulmonary Dysplasia in Children

Centre Hospitalier Intercommunal Creteil2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2018年3月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
80
试验地点
2
主要终点
p16 expression

研究概览

简要总结

The bronchopulmonary dysplasia (BPD) is a respiratory disease of the premature child which lead to a reduction of gas exchange surface and to a prolonged respiratory failure. This disease has morphologic and functional consequences at adulthood and is today considered to be an early determinant of respiratory diseases at adulthood.

The physiopathology of BPD is not well known. Several mechanisms could be involved especially a reparation failure favored by an increase of cellular senescence which is a permanent stop of cellular proliferation. The transcription factor 16 Ink4a, considered as a marker of aging, is one of the essential markers of senescence. Its increase during prematurity was shown at the blood cells of the cordon, but its involvement in BPD and its evolution in child are not yet studied.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
— 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Premature(< 28 GA) neonates
  • Alive neonate born at less than 28 gestational age
  • Signed inform consent
  • Term neonates:
  • Alive neonate born at least at 37 GA or more
  • Signed inform consent
  • Child from 7 to 15 years old with BPD:
  • Child from 7 to 15 years old
  • Child with a BPD diagnosed
  • Signed inform consent
  • Child from 7 to 15 years old without BPD:
  • Child from 7 to 15 years old
  • Child receiving a blood test
  • Signed inform consent

排除标准

  • Premature (< 28 GA) and term neonates:
  • Congenital malformation
  • Child from 7 to 15 years old with BPD:
  • Cystic fibrosis
  • Evolutive cancer
  • Chronic inflammatory disease
  • Known anemia
  • Refusal of participation of child or parental authority
  • Child from 7 to 15 years old without BPD:
  • Other respiratory disease: severe asthma, cystic fibrosis, deficit AAT, bronchial dilatation
  • Evolutive cancer
  • Chronic inflammatory disease
  • Known anemia
  • Refusal of participation of child or parental authority

结局指标

主要结局

p16 expression

时间窗: Day 1

p16 expression measured by qPCR in newborns cord blood cells and in circulating leukocytes of children aged from 7 to 15

次要结局

  • Telomeres length(Day 1)
  • Genetic expression of p21, p53, H2Ax(Day 1)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验